Ikonisys Future Growth
Future criteria checks 5/6
Ikonisys is forecast to grow earnings and revenue by 84.2% and 51% per annum respectively. EPS is expected to grow by 85% per annum. Return on equity is forecast to be 4.7% in 3 years.
Key information
84.2%
Earnings growth rate
85.0%
EPS growth rate
Medical Equipment earnings growth | 15.4% |
Revenue growth rate | 51.0% |
Future return on equity | 4.7% |
Analyst coverage | Low |
Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 10 | 0 | 4 | N/A | 2 |
12/31/2025 | 6 | -1 | 2 | N/A | 2 |
12/31/2024 | 1 | -2 | -2 | N/A | 1 |
6/30/2024 | 0 | -3 | N/A | N/A | N/A |
3/31/2024 | 0 | -2 | N/A | N/A | N/A |
12/31/2023 | 0 | -2 | -1 | -1 | N/A |
9/30/2023 | 1 | -2 | N/A | N/A | N/A |
6/30/2023 | 1 | -2 | -2 | -1 | N/A |
3/31/2023 | 1 | -2 | -2 | -1 | N/A |
12/31/2022 | 1 | -2 | -2 | -1 | N/A |
9/30/2022 | 1 | -2 | N/A | N/A | N/A |
6/30/2022 | 1 | -1 | -2 | -2 | N/A |
3/31/2022 | 1 | -1 | -2 | -1 | N/A |
12/31/2021 | 1 | -1 | -1 | -1 | N/A |
9/30/2021 | 0 | -1 | N/A | N/A | N/A |
6/30/2021 | 0 | -1 | N/A | N/A | N/A |
3/31/2021 | 0 | -1 | N/A | N/A | N/A |
12/31/2020 | 0 | -2 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALIKO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.4%).
Earnings vs Market: ALIKO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALIKO is expected to become profitable in the next 3 years.
Revenue vs Market: ALIKO's revenue (51% per year) is forecast to grow faster than the French market (5.6% per year).
High Growth Revenue: ALIKO's revenue (51% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ALIKO's Return on Equity is forecast to be low in 3 years time (4.7%).